The recently introduced Total Thrombus-Formation Analysis System (T-TAS), is a microchip-based flow chamber system designed to evaluate thrombogenicity in whole blood.
Hart Biologicals is proud to be celebrating a very special milestone in 2019. 10 years of the Rivergreen Business Centre in Hartlepool.
As Hart Biologicals celebrates its 10th anniversary since moving into its current headquarters location at Rivergreen Business Centre on the outskirts of Hartlepool, much has changed since those early days in September 2009.
Hart Biologicals prides itself on its passionate and determined range of departments, with production at the forefront of manufacturing, packaging and labelling.
Hart Biologicals has recently bid farewell to one of their own who is retiring after a 40+ year career.
North East medical manufacturer, Hart Biologicals, has been acquired by new investors who aim to welcome in a new chapter for the business.
Sales Manager, Paul Bates, reviews the benefits of both point of care testing and laboratory testing.
Hart Biologicals has announced the availability of its new Ristocetin MEA Test kit.
Hart Biologicals recently showcased an innovative product at the UK NEQAS for Blood Coagulation Clinical and Laboratory Haemostasis meeting at Sheffield Hallam University.
Hart Biologicals is getting ready to present at this year’s UK NEQAS at Sheffield Hallam Universityand will be bringing along one of its latest products, the T-TAS 01.
A member of the Hart Biologicals team is backing a charity which supports Police Officers across the UK after a close family friend sadly passed away.
Mental health first aiders have been trained to raise awareness and promote positive Mental Health and Wellbeing in their workplace.